SCHEMBL441623

SCHEMBL441623

COC1CCC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7762508 0.86
SCHEMBL7522014 0.85 CA1 (0.35)
SCHEMBL11512048 0.83 KMT2A (0.38)
SCHEMBL11532054 0.83 KMT2A (0.38)
SCHEMBL12676984 0.82
SCHEMBL9514913 0.77
SCHEMBL15088521 0.77
SCHEMBL16359177 0.77
SCHEMBL8224538 0.77
SCHEMBL9621721 0.76 ATM (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12016358-B2 Composition comprising taste modulation compounds, their use and foodstuff comprising them V. MANE FILS (FR) 2024-06-25 US claimed
US-11632973-B2 Composition comprising taste modulation compounds, their use and foodstuff comprising them V. MANE FILS (FR) 2023-04-25 US claimed
US-20220023381-A1 VDAC INHIBITORS FOR TREATING AUTOIMMUNE DISEASES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES 2022-01-27 US claimed
US-20220023382-A1 VDAC INHIBITORS FOR TREATING INFLAMMATORY BOWEL DISEASES The National Institute for Biotechnology in the Negev Ltd. (IL) 2022-01-27 US claimed
EP-3886850-A1 VDAC INHIBITORS FOR TREATING INFLAMMATORY BOWEL DISEASES National Institute for Biotechnology in the Negev Ltd. (IL) 2021-10-06 EP claimed
EP-3886849-A1 VDAC INHIBITORS FOR TREATING AUTOIMMUNE DISEASES The National Institute for Biotechnology in the Negev, Ltd. (IL) 2021-10-06 EP claimed
EP-3331381-B1 COMPOSITION COMPRISING TASTE MODULATION COMPOUNDS THEIR USE AND FOODSTUFF COMPRISING THEM V MANE FILS (FR) 2021-10-06 EP claimed
CN-113365627-A VDAC inhibitors for the treatment of inflammatory bowel disease 国家生物技术研究所公司 2021-09-07 CN claimed
CN-113347973-A VDAC inhibitors for the treatment of autoimmune diseases 国家生物技术研究所公司 2021-09-03 CN claimed
US-20210130291-A1 METHODS FOR TREATING DIABETES USING VDAC1 INHIBITORS The National Institute for Biotechnology in the Negev Ltd. (IL) 2021-05-06 US claimed
EP-3331380-A1 COMPOSITION COMPRISING TASTE MODULATION COMPOUNDS, THEIR USE AND FOODSTUFF COMPRISING THEM V. Mane Fils (FR) 2018-06-13 EP claimed
US-20180118700-A1 NOVEL PIPERAZINE AND PIPERIDINE DERIVATIVES, THEIR SYNTHESIS AND USE THEREOF IN INHIBITING VDAC OLIGOMERIZATION, APOPTOSIS AND MITOCHONDRIA DYSFUNCTION The National Institute for Biotechnology in the Negev Ltd. (IL) 2018-05-03 US claimed
US-20180078548-A1 Methods for Treating Central Nervous System Disorders Using VDAC Inhibitors The National Institute for Biotechnology in the Negev Ltd. (IL) 2018-03-22 US claimed
WO-2017046794-A1 NOVEL PIPERAZINE AND PIPERIDINE DERIVATIVES, THEIR SYNTHESIS AND USE THEREOF IN INHIBITING VDAC OLIGOMERIZATION, APOPTOSIS AND MITOCHONDRIA DYSFUNCTION The National Institute for Biotechnology in the Negev Ltd. (IL) 2017-03-23 WO claimed
WO-2017025811-A1 COMPOSITION COMPRISING TASTE MODULATION COMPOUNDS, THEIR USE AND FOODSTUFF COMPRISING THEM V. MANE FILS (FR) 2017-02-16 WO claimed
WO-2017025804-A1 COMPOSITION COMPRISING TASTE MODULATION COMPOUNDS, THEIR USE AND FOODSTUFF COMPRISING THEM V. MANE FILS (FR) 2017-02-16 WO claimed
WO-2017025810-A2 COMPOSITION COMPRISING TASTE MODULATION COMPOUNDS, THEIR USE AND FOODSTUFF COMPRISING THEM V. MANE FILS (FR) 2017-02-16 WO claimed
EP-1613481-B1 ORGANIC SILVER COMPOUND AND IT'S PREPARATION METHOD, ORGANIC SILVER INK AND IT'S DIRECT WIRING METHOD HAEUN CHEMTEC CO LTD (KR) 2013-09-04 EP claimed
US-20100163070-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBRES USING HEATING MEANS AND AN AMIDE L'OREAL S.A. (FR) 2010-07-01 US claimed
EP-0809103-A2 Stable denaturants for use in electrophoretic techniques and methods of using the same FMC CORPORATION (US) 1997-11-26 EP claimed